WorksheetsENIGMA Post-Test
Total questions: 8
Worksheet time: 4mins
What is the prevalence rate of mixed phenotypic leukemia from all types of leukemia?
1-2%
2-5%
5-10%
10-15%
True for Philadelphia chromosome positive MPAL
More common in males
Good prognosis
Low relapse rate
TKI has no role in treatment
More commonly seen in mixed phenotype acute leukemia as compared to AML or ALL patients
Fever
Lymphadenopathy
Hepatomegaly
Splenomegaly
This is the key lineage defining marker for B lineage
CD19
CD3
MPO
CD14
Monocytic differentiation is defined by the presence of at least two of the following markers except:
CD11c
CD14
CD64
CD3
The following is/are the risk factor/s for developing leukemia
a. Smoking
History of previous cancer treatments
Exposure to carcinogens
All of the above
The Monoclonal antibody anti-MPO was expressed in at least 5% of blasts in 98% of cases for Myeloid lineage
TRUE
FALSE
MPAL has been regarded to have high disease resistance and inferior survival.
TRUE
FALSE
